Institutional investors purchased a net $479.9 thousand shares of PBYI during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 94.08% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBUS CIRCLE INVESTORS Bought 179.9 Thousand shares of Puma Biotechnology Inc